Droperidol and 5-HT3-receptor antagonists, alone or in combination, for prophylaxis of postoperative nausea and vomiting. A meta-analysis of randomised controlled trials.
about
Evolving ideas about the male refractory periodDimenhydrinate for prophylaxis of postoperative nausea and vomiting: a meta-analysis of randomized controlled trials.Combination of gabapentin and ramosetron for the prevention of postoperative nausea and vomiting after gynecologic laparoscopic surgery: a prospective randomized comparative study.Higher dose of palonosetron versus lower dose of palonosetron plus droperidol to prevent postoperative nausea and vomiting after eye enucleation and orbital hydroxyapatite implant surgery: a randomized, double-blind trialThe influence of a dominating centre on a quantitative systematic review of granisetron for preventing postoperative nausea and vomiting.Nausea and vomiting after surgery under general anesthesia: an evidence-based review concerning risk assessment, prevention, and treatment.Prophylactic antiemetic effects in gynecologic patients receiving fentanyl IV-patient controlled analgesia: comparison of combined treatment with ondansetron and dexamethasone with metoclopramide and dexamethasone.How to study postoperative nausea and vomiting.Polymorphism of μ-Opioid Receptor Gene (OPRM1:c.118A>G) Might Not Protect against or Enhance Morphine-Induced Nausea or VomitingPrevention of postoperative nausea and vomiting.Recent advances, trends and economic considerations in the risk assessment, prevention and treatment of postoperative nausea and vomiting.Combination of antiemetics for the prevention of postoperative nausea and vomiting in high-risk patients.Management of postoperative nausea and vomiting: focus on palonosetronPopulation pharmacokinetics and prophylactic anti-emetic efficacy of ramosetron in surgical patients.Aprepitant as a fourth antiemetic prophylactic strategy in high-risk patients: a double-blind, randomized trial.
P2860
Q28286807-604AA71B-0AE5-43C9-9B78-F6F8BB6AE47EQ30700954-B9F563F5-4A74-45D8-87A1-3819A0299A96Q33709126-E3A2477E-D8C4-4EE8-9603-D2C8A4E04937Q33713958-D1D2231C-25A8-491E-A8B9-C5FAF1AD3E61Q34291134-CC860B81-A1F8-45A2-9818-25FAAC0658BEQ34296514-9A076386-CE46-4E02-9BE2-2687B0E84376Q34388886-770838A8-D9BF-42BD-A03D-1672168363CDQ34792278-6033C980-8FC8-4E0B-9BE1-C72E10A14BF2Q36619142-7789F5D4-CEC2-4AC5-B22A-DA7C23380EEFQ36698017-7463B9F0-13B7-489B-9C28-E7C7970CCB81Q37013063-3B0CA157-2358-4843-9AF9-D7854BF58097Q37221224-FD8B6F0A-761B-4BD7-916B-AE58EAC32EEBQ37230293-0426324A-CDD1-4E13-AD3B-CA541FB1CA81Q41991414-06697AD3-08A8-40FF-AD19-29AC7A42C7FAQ47213849-75DDCEB8-23F3-43A6-965C-81B675C7AC9C
P2860
Droperidol and 5-HT3-receptor antagonists, alone or in combination, for prophylaxis of postoperative nausea and vomiting. A meta-analysis of randomised controlled trials.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Droperidol and 5-HT3-receptor ...... randomised controlled trials.
@ast
Droperidol and 5-HT3-receptor ...... randomised controlled trials.
@en
type
label
Droperidol and 5-HT3-receptor ...... randomised controlled trials.
@ast
Droperidol and 5-HT3-receptor ...... randomised controlled trials.
@en
prefLabel
Droperidol and 5-HT3-receptor ...... randomised controlled trials.
@ast
Droperidol and 5-HT3-receptor ...... randomised controlled trials.
@en
P2093
P2860
P1476
Droperidol and 5-HT3-receptor ...... randomised controlled trials.
@en
P2093
Eberhart LH
Georgieff M
P2860
P304
P356
10.1034/J.1399-6576.2000.441011.X
P407
P577
2000-11-01T00:00:00Z